--- title: "EDAP TMS SA (FOCL) stock listing, news and investor profile" url: "https://aibio.space/companies/edap-tms/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "EDAP TMS SA (NASDAQ: FOCL), United States. Listing facts, related biotech companies and news on aibio.space." --- FOCL EDAP TMS SA NASDAQ · United States # EDAP TMS SA (FOCL) news EDAP TMS SA is a public biotech or pharmaceutical company listed on NASDAQ under the ticker FOCL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest EDAP TMS SA news We have not published a story on EDAP TMS SA yet. When there is news, it will appear here. ## EDAP TMS SA at a glance - **Ticker**: FOCL - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $21.5 million ### Related companies - [SHOULDER INNOVATIONS, INC.](https://aibio.space/companies/shoulder-innovations/) NYSE: SI - [Revium Rx.](https://aibio.space/companies/revium-rx/) OTC: RVRC - [NEUROONE MEDICAL TECHNOLOGIES](https://aibio.space/companies/neuroone-medical-technologies/) NASDAQ: NMTC - [ORGANIGRAM GLOBAL INC.](https://aibio.space/companies/organigram-global/) NASDAQ: OGI - [ALPHA PRO TECH LTD](https://aibio.space/companies/alpha-pro-tech/) NYSE: APT - [Leef Brands](https://aibio.space/companies/leef-brands/) OTC: LEEEF - [CASTLE BIOSCIENCES INC](https://aibio.space/companies/castle-biosciences/) NASDAQ: CSTL - [UL Solutions](https://aibio.space/companies/ul-solutions/) NYSE: ULS ### Also on NASDAQ - [Anbio Biotechnology](https://aibio.space/companies/anbio-biotechnology/) NNNN - [Aspire-Lakewood Holdings](https://aibio.space/companies/aspire-lakewood/) ASBP - [Beam Therapeutics](https://aibio.space/companies/beam-therapeutics/) BEAM - [NeuroSense Therapeutics](https://aibio.space/companies/neurosense-therapeutics/) NRSN - [Psyence Biomedical](https://aibio.space/companies/psyence-biomedical/) PBM - [Wave Life Sciences](https://aibio.space/companies/wave-life-sciences/) WVE ## EDAP TMS SA annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$70.5 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | [$69.4 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Research and development | [$9.7 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | [$8.4 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Net income (loss) | [-$29.2 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | [-$20.6 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Cash from operations | [-$16.4 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | [-$14.7 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Cash and equivalents | [$20.5 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926097063/) | [$31.0 million](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Short-term investments | [$0](https://www.sec.gov/Archives/edgar/data/1041934/000110465926034528/) | | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $21.5 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about EDAP TMS SA What is the ticker symbol of EDAP TMS SA? EDAP TMS SA trades under the ticker FOCL on NASDAQ. Where is EDAP TMS SA listed? EDAP TMS SA is listed on NASDAQ. Which country or territory is EDAP TMS SA listed under? Our directory records EDAP TMS SA under United States. Does aibio.space cover EDAP TMS SA? aibio.space lists EDAP TMS SA among 2,820 public biotech companies and publishes its news here as stories appear. What was EDAP TMS SA's revenue last year? $70.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is EDAP TMS SA profitable? EDAP TMS SA reported a net loss of $29.2 million for the fiscal year ended Dec 31, 2025, and used $16.4 million of cash in operations, per its annual report to the SEC. How much does EDAP TMS SA spend on research and development? $9.7 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does EDAP TMS SA have? $21.5 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: EDAP TMS SA Members talk about EDAP TMS SA (FOCL). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at EDAP TMS SA, newest first. Each line links the filing it comes from. 1. 2026-08-12 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1041934/000110465926094278/tm2622525-1_424b5.htm) 2. 2026-05-29 Financings Reported a financing. SEC Form 8-K (Items 8.01). [Source](https://www.sec.gov/Archives/edgar/data/1041934/000117184326003773/exh_991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:FOCL on TradingView](https://www.tradingview.com/symbols/NASDAQ-FOCL/). ## Listing details EDAP TMS SA is a public biotech or pharmaceutical company listed on NASDAQ under the ticker FOCL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: EDAP TMS SA - **Ticker**: FOCL - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/edap-tms/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "EDAP TMS SA (FOCL) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/edap-tms/